AGP Executive Report
Last update: 9 hours agoCourt Ruling Impacting Local Banking: Switzerland’s Federal Administrative Court has overturned all substantive orders in a FINMA enforcement case tied to VP Bank (Zurich), a Liechtenstein-listed group, after a June 16 judgment published July 1—raising fresh questions about how regulators handle high-profile actions. Health & Pharma Deal in the Region: Hansa Biopharma says its €115m exclusive licensing deal for Idefirix has closed with SERB, aiming to expand access for highly sensitised kidney transplant patients across the EU plus Switzerland, Norway, Liechtenstein and more. Antimicrobial Resistance Policy Push: EU/EEA health payers are looking at shared pricing and reimbursement models—highlighting a Nordic approach that combines cross-border antibiotic purchasing with supplier remuneration to help tackle drug resistance. Reproductive Health Politics: Prince Alois of Liechtenstein says he will veto a proposed abortion law reform that would allow abortion within the first 12 weeks, reigniting debate over current exception-based rules. Rural Health Context: A new global map shows Liechtenstein among the small set of countries where more than half the population is still rural (85.29%), a useful backdrop for planning access to care.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
